title: Pathological trans-lesion synthesis in cancer.
authors.affiliation: a Department of Pathology and Laboratory Medicine , University of North Carolina at Chapel Hill , Chapel Hill , NC , USA.
authors.forename: Yanzhe
authors.initials: Y
authors.lastname: Gao
authors.affiliation: b Division of Cell Maintenance, Institute of Molecular Embryology and Genetics (IMEG), Kumamoto University , Kumamoto , Japan.
authors.forename: Satoshi
authors.initials: S
authors.lastname: Tateishi
authors.affiliation: a Department of Pathology and Laboratory Medicine , University of North Carolina at Chapel Hill , Chapel Hill , NC , USA.
authors.forename: Cyrus
authors.initials: C
authors.lastname: Vaziri
mesh_terms: D004249:DNA Damage; D004268:DNA-Binding Proteins / Q000378:metabolism; D004259:DNA-Directed DNA Polymerase / Q000378:metabolism*; D006801:Humans; D058950:Melanoma-Specific Antigens / Q000378:metabolism; D016296:Mutagenesis; D009369:Neoplasms / Q000201:enzymology / Q000235:genetics* / Q000473:pathology*; D044767:Ubiquitin-Protein Ligases / Q000378:metabolism
chemical_list: D004268:DNA-Binding Proteins; D058950:Melanoma-Specific Antigens; C485954:RAD18 protein, human; D044767:Ubiquitin-Protein Ligases; D004259:DNA-Directed DNA Polymerase
keywords: DNA damage; RAD18; cancer-testes antigens (CTA); genome maintenance; melanoma antigen-A4 (MAGE-A4); mutagenesis; trans-lesion synthesis (TLS)